---
title: Malaria
permalink: /malaria/
variant: tiptap
description: ""
third_nav_title: M to S
---
<h2>Overview</h2>
<p>Malaria is a disease caused by a protozoan parasite, Plasmodium. Singapore
was certified malaria-free by the WHO in Nov 1982.&nbsp;</p>
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>Pathogen(s)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Four different <em>Plasmodium</em> spe<em>cies: P. falciparum, P. vivax, P. ovale&nbsp;</em>and&nbsp;<em>P. malariae.</em>
</p>
<p>In recent years,&nbsp;<em>P knowlesi,&nbsp;</em>a parasite of Old-World
monkeys has been identified as the fifth major human malaria parasite.
It is an emerging infection in SE Asia and is capable of causing serious
life-threatening complications and death in a minority of cases.</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Transmission</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p>Transmitted via bite of infective Anopheles mosquito. Transmission can
also occur vertically (mother-to-child), via contaminated blood transfusion
or organ transplant.</p>
</li>
<li>
<p>Incubation period: Ranges from 7 – 30 days (varies by species)</p>
<ul data-tight="true" class="tight">
<li>
<p><em>P. falciparum</em>: 9 – 14 days</p>
</li>
<li>
<p><em>P. vivax</em> and <em>P. ovale</em>: 12 – 18 days<em> </em>(up to 6
– 12 months for some<em> P. vivax </em>strains)</p>
</li>
<li>
<p><em>P. malariae</em>: 18 – 40 days</p>
</li>
<li>
<p><em>P. knowlesi</em>: 9 – 12 days</p>
</li>
</ul>
</li>
<li>
<p>Infectious period: Infectious to mosquitoes as long as parasites (infective
gametocytes) are present in the blood</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Clinical Features</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p><strong>Symptoms</strong>
</p>
<ul data-tight="true" class="tight">
<li>
<p>Fever, chills, rigors</p>
</li>
</ul>
<p><strong>Signs</strong>
</p>
<ul data-tight="true" class="tight">
<li>
<p>Hepatosplenomegaly sometimes present</p>
</li>
</ul>
<p><strong>Severe falciparum malaria</strong>
</p>
<p>Defined by presence of any of the following features:</p>
<ul data-tight="true" class="tight">
<li>
<p>Clinical</p>
<ul data-tight="true" class="tight">
<li>
<p>impaired consciousness or unrousable coma</p>
</li>
<li>
<p>prostration, i.e. generalized weakness so that the patient is unable to
walk or sit up without assistance</p>
</li>
<li>
<p>failure to feed</p>
</li>
<li>
<p>multiple convulsions – more than two episodes in 24 h</p>
</li>
<li>
<p>deep breathing, respiratory distress (acidotic breathing)</p>
</li>
<li>
<p>circulatory collapse or shock, systolic blood pressure &lt; 70 mm Hg in
adults and &lt; 50 mm Hg in children</p>
</li>
<li>
<p>clinical jaundice plus evidence of other vital organ dysfunction</p>
</li>
<li>
<p>haemoglobinuria</p>
</li>
<li>
<p>abnormal spontaneous bleeding</p>
</li>
<li>
<p>pulmonary oedema (radiological)</p>
</li>
</ul>
</li>
<li>
<p>Laboratory</p>
<ul data-tight="true" class="tight">
<li>
<p>hypoglycaemia (blood glucose &lt; 2.2 mmol/l or &lt; 40 mg/dl)</p>
</li>
<li>
<p>metabolic acidosis (plasma bicarbonate &lt; 15 mmol/l)</p>
</li>
<li>
<p>severe normocytic anaemia (Hb &lt; 5 g/dl, packed cell volume &lt; 15%)</p>
</li>
<li>
<p>haemoglobinuria</p>
</li>
<li>
<p>hyperparasitaemia (&gt; 2%/100 000/μl in low intensity transmission areas
or &gt; 5% or 250 000/μl in areas of high stable malaria transmission intensity)</p>
</li>
<li>
<p>hyperlactataemia (lactate &gt; 5 mmol/l)</p>
</li>
<li>
<p>renal impairment (serum creatinine &gt; 265 μmol/l)</p>
</li>
</ul>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Risk Factors</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Living in/ travelling to malaria-affected areas.</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Diagnosis</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p>Examination of thick and thin blood films (repeat 12 hourly for 48 hours
if the diagnosis is considered likely and initial films are negative).</p>
</li>
<li>
<p>Rapid diagnostic tests (RDTs) offer a useful alternative to microscopy
in situations where reliable microscopic diagnosis is not available</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Treatment and Management</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p>Cases should be treated in hospital until parasitaemia has cleared.</p>
</li>
<li>
<p>Non-falciparum malaria: chloroquine 600 mg stat, then 300 mg X 3 daily
doses. Primaquine 15mg daily for 2 weeks to eliminate hepatic stage (check
G6PD levels first).</p>
</li>
<li>
<p>Falciparum malaria, mild: Artemisinin-based combination therapies preferred.
Alternative choice is oral quinine 600 mg tds for 7 days, together with
doxycycline 100 mg bd for 7 days.</p>
</li>
<li>
<p>Falciparum malaria, severe (as defined above): a medical emergency. Treatment
is urgent and experience with severe malaria is essential. Intravenous
(IV) artesunate plus clindamycin&nbsp;<em>or&nbsp;</em>doxycycline is treatment
of choice for severe malaria. Intravenous quinine plus doxycycline is an
alternative.&nbsp; Meticulous fluid management, regular monitoring of blood
sugar and supportive therapy for organ dysfunction as required. Exchange
transfusion may be considered for high parasitaemia with complications,
but the indications and level of parasitaemia are controversial.</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Precaution, Prevention and Control</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p>Standard precautions apply in the healthcare setting.</p>
</li>
<li>
<p>For personal protective measures for travellers to endemic areas:</p>
<ul data-tight="true" class="tight">
<li>
<p>Appropriate chemoprophylaxis should be started before travel.</p>
</li>
<li>
<p>Avoid exposure between dusk and dawn as this is when the female anopheline
mosquito is active.</p>
</li>
<li>
<p>Wear long-sleeves light-coloured clothing.</p>
</li>
<li>
<p>Use mosquito repellent containing 10% to 30% DEET.</p>
</li>
<li>
<p>Use mosquito coils.</p>
</li>
<li>
<p>Consider treating clothes with permethrin-based products.</p>
</li>
<li>
<p>Sleep under impregnated mosquito netting and keep to well-screened or
air-conditioned rooms.</p>
</li>
</ul>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Notification</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p>Who should notify:</p>
<ul data-tight="true" class="tight">
<li>
<p>Medical practitioners and laboratories</p>
</li>
</ul>
</li>
<li>
<p>When to notify:</p>
<ul data-tight="true" class="tight">
<li>
<p>On clinical suspicion/ laboratory confirmation</p>
</li>
</ul>
</li>
<li>
<p>How to notify</p>
<ul data-tight="true" class="tight">
<li>
<p>Submit MD131 Notification of Infectious Diseases Form via CDLENS (<a rel="noopener noreferrer nofollow" target="_blank">http://www.cdlens.moh.gov.sg</a>) or
fax (6221-5528/38/67)</p>
</li>
</ul>
</li>
<li>
<p>Timeline on notification</p>
<ul data-tight="true" class="tight">
<li>
<p>As soon as possible. No later than 24 hours from the time of diagnosis</p>
</li>
</ul>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Resources</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Please refer to the MOH Weekly Infectious Diseases Bulletin for the numbers
of confirmed malaria cases in Singapore.</p>
</div>
</details>
</div>
<p></p>